Published in N Engl J Med on December 20, 2001
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med (2007) 10.43
Oral contraceptives and myocardial infarction--the search for the smoking gun. N Engl J Med (2001) 1.64
52-year-old woman with intractable nausea and vomiting. Mayo Clin Proc (2010) 1.38
Higher risk of venous thrombosis associated with drospirenone-containing oral contraceptives: a population-based cohort study. CMAJ (2011) 1.38
Contraceptive hormone use and cardiovascular disease. J Am Coll Cardiol (2009) 1.31
Is the difference in outcome between men and women treated by primary percutaneous coronary intervention age dependent? Gender difference in STEMI stratified on age. Eur Heart J Acute Cardiovasc Care (2013) 1.12
Ischemic heart disease in women: a focus on risk factors. Trends Cardiovasc Med (2014) 0.87
Application of electrospun fibers for female reproductive health. Drug Deliv Transl Res (2017) 0.84
Oral contraceptives and myocardial infarction. CMAJ (2002) 0.83
Estrogens, selective estrogen receptor modulators, and a selective estrogen receptor down-regulator inhibit endothelial production of tissue factor pathway inhibitor 1. BMC Cardiovasc Disord (2006) 0.81
Dutch women with a low birth weight have an increased risk of myocardial infarction later in life: a case control study. Reprod Health (2005) 0.80
In silico identification of drug targets for antifertility from natural products by differential reaction content analysis of metabolic pathways. Malays J Med Sci (2011) 0.78
Infertility, fertility treatment, and risk of hypertension. Fertil Steril (2015) 0.76
Effect of Oral Contraceptive Pills on the Blood Serum Enzymes and DNA Damage in Lymphocytes Among Users. Indian J Clin Biochem (2015) 0.75
Novel contraceptive targets to inhibit ovulation: the prostaglandin E2 pathway. Hum Reprod Update (2015) 0.75
Oral contraceptives and the risk of myocardial infarction. N Engl J Med (2002) 0.75
Oral contraceptives and the risk of myocardial infarction. N Engl J Med (2002) 0.75
Attitudes Toward Prohibiting Tobacco Sales in Pharmacy Stores Among U.S. Adults. Am J Prev Med (2016) 0.75
Coronary artery disease in women: a review on prevention, pathophysiology, diagnosis, and treatment. Vasc Health Risk Manag (2006) 0.75
The drop that spilled the cup: acute myocardial infarction in a young woman with underlying thrombophilic polymorphisms and oral contraceptive use. Case Rep Cardiol (2014) 0.75
Oral contraceptive progestins and angiotensin-dependent control of the renal circulation in humans. J Hum Hypertens (2009) 0.75
Acute coronary syndrome in women of reproductive age. Int J Womens Health (2011) 0.75
Oral contraceptives and the risk of myocardial infarction. N Engl J Med (2002) 0.75
Oral contraceptives and the risk of myocardial infarction. N Engl J Med (2002) 0.75
Oral contraceptives and the risk of myocardial infarction. N Engl J Med (2002) 0.75
Cardiometabolic Features of Polycystic Ovary Syndrome: Role of Androgens. Physiology (Bethesda) (2017) 0.75
Tailoring cardiovascular risk assessment and prevention for women: One size does not fit all. Glob Cardiol Sci Pract (2017) 0.75
Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet (2006) 10.72
Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature (1994) 9.06
The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA (1995) 7.31
Comparison of conventional anterior surgery and laparoscopic surgery for inguinal-hernia repair. N Engl J Med (1997) 6.20
Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet (1994) 5.58
Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet (1994) 5.45
Laparoscopic or conventional Nissen fundoplication for gastro-oesophageal reflux disease: randomised clinical trial. The Netherlands Antireflux Surgery Study Group. Lancet (2000) 5.31
Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med (1995) 5.16
Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen. Lancet (1995) 5.10
End of the line for "third-generation-pill" controversy? Lancet (1997) 4.63
The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study. BMJ (2009) 4.18
Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis. Lancet (1992) 4.15
Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke (1997) 4.13
Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke (1998) 4.12
Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med (1996) 4.11
Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost (2007) 4.09
Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet (1995) 4.01
[Breast cancer and the use of the hormones around the menopause]. Ned Tijdschr Geneeskd (2003) 3.86
Incidence of subarachnoid hemorrhage: role of region, year, and rate of computed tomography: a meta-analysis. Stroke (1996) 3.67
Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation (1994) 3.65
Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke (2003) 3.56
Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study. J Thromb Haemost (2006) 3.49
Long-term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: a cohort study. Lancet (2005) 3.46
Increased fetal loss in women with heritable thrombophilia. Lancet (1996) 3.34
Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry (2007) 3.17
Is publication bias a medical problem? Lancet (1993) 3.04
Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med (1990) 2.79
Assessment and control for confounding by indication in observational studies. J Am Geriatr Soc (1999) 2.71
Bleeding complications in oral anticoagulant therapy. An analysis of risk factors. Arch Intern Med (1993) 2.70
Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke (2005) 2.69
Percutaneous vertebroplasty compared with optimal pain medication treatment: short-term clinical outcome of patients with subacute or chronic painful osteoporotic vertebral compression fractures. The VERTOS study. AJNR Am J Neuroradiol (2007) 2.66
Oral contraceptives and the risk of venous thrombosis. N Engl J Med (2001) 2.57
How to assess the external validity of therapeutic trials: a conceptual approach. Int J Epidemiol (2009) 2.49
Treatment of intracranial aneurysms by embolization with coils: a systematic review. Stroke (1999) 2.49
Third generation oral contraceptives and risk of venous thrombosis: meta-analysis. BMJ (2001) 2.43
Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systematic review. Neurology (1998) 2.39
High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med (2000) 2.39
Antipsychotic medication and venous thrombosis. Br J Psychiatry (2001) 2.37
Association of intraoperative transcranial doppler monitoring variables with stroke from carotid endarterectomy. Stroke (2000) 2.33
Activation of coagulation system during air travel: a crossover study. Lancet (2006) 2.32
Circle of Willis: morphologic variation on three-dimensional time-of-flight MR angiograms. Radiology (1998) 2.30
Cigarette smoking and the risk of venous thromboembolism: the Tromsø Study. J Thromb Haemost (2012) 2.30
Risk, causes, and prevention of ischaemic stroke in elderly patients with symptomatic internal-carotid-artery stenosis. Lancet (2001) 2.29
Interaction of coagulation defects and cardiovascular risk factors: increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A. Circulation (1998) 2.26
Long-term benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5 year follow-up of a trial conducted by the Interuniversity Cardiology Institute of The Netherlands. J Am Coll Cardiol (1989) 2.23
Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease. JAMA (1999) 2.21
Mortality due to pulmonary embolism, myocardial infarction, and stroke among incident dialysis patients. J Thromb Haemost (2012) 2.17
Effectiveness of the postcoital test: randomised controlled trial. BMJ (1998) 2.15
Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors. Circulation (1995) 2.13
Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT). J Thromb Haemost (2005) 2.13
Patients with type 3 severe von Willebrand disease are not protected against atherosclerosis: results from a multicenter study in 47 patients. Circulation (2004) 2.12
Factor V Leiden: should we screen oral contraceptive users and pregnant women? BMJ (1996) 2.11
Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study) Blood (1995) 2.09
Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (2007) 2.08
Psychosocial intervention following suicide attempt: a systematic review of treatment interventions. Acta Psychiatr Scand (1997) 2.06
Use of preventive measures for air travel-related venous thrombosis in professionals who attend medical conferences. J Thromb Haemost (2006) 2.06
Current perspective of venous thrombosis in the upper extremity. J Thromb Haemost (2008) 2.06
Ticlopidine, trials, and torture. Stroke (1994) 2.04
Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions. Thromb Haemost (1999) 2.04
The family history and inherited thrombophilia. Br J Haematol (1994) 2.03
Secondary prevention after cerebral ischaemia of presumed arterial origin: is aspirin still the touchstone? J Neurol Neurosurg Psychiatry (1999) 2.03
[Evaluation of added value of diagnostic tests]. Ned Tijdschr Geneeskd (2000) 2.02
Mortality and causes of death in patients with hemophilia, 1992-2001: a prospective cohort study. J Thromb Haemost (2006) 2.01
Seasonal variation of venous thrombosis: a consecutive case series within studies from Leiden, Milan and Tromsø. J Thromb Haemost (2012) 2.01
Inherited thrombophilia: Part 1. Thromb Haemost (1996) 2.00
Idiopathic thrombocytopenic purpura in pregnancy: a randomized trial on the effect of antenatal low dose corticosteroids on neonatal platelet count. Br J Obstet Gynaecol (1990) 2.00
Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis? Lancet (1995) 2.00
Mortality from venous thromboembolism and myocardial infarction in young women in the Netherlands. Lancet (1996) 1.99
Incidence of psychotic disorders in immigrant groups to The Netherlands. Br J Psychiatry (2001) 1.99
Do patients with sore throat benefit from penicillin? A randomized double-blind placebo-controlled clinical trial with penicillin V in general practice. Br J Gen Pract (1996) 1.97
Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect. Lancet (1993) 1.96
Risk of venous thrombosis with use of current low-dose oral contraceptives is not explained by diagnostic suspicion and referral bias. Arch Intern Med (1999) 1.95
Age at menopause as a risk factor for cardiovascular mortality. Lancet (1996) 1.94
Extrahepatic portal vein thrombosis: aetiology and determinants of survival. Gut (2001) 1.86
Follow-up screening after subarachnoid haemorrhage: frequency and determinants of new aneurysms and enlargement of existing aneurysms. Brain (2005) 1.85
Cost-effectiveness of extraperitoneal laparoscopic inguinal hernia repair: a randomized comparison with conventional herniorrhaphy. Coala trial group. Ann Surg (1997) 1.85
von Willebrand factor and its propeptide: the influence of secretion and clearance on protein levels and the risk of venous thrombosis. J Thromb Haemost (2006) 1.84
Second-generation recombinant factor VIII and inhibitor risk: interpretation of RODIN study findings and implications for patients with haemophilia A. Haemophilia (2013) 1.84
Mortality and morbidity of surgery for unruptured intracranial aneurysms: a meta-analysis. Stroke (1998) 1.82
Recurrent ischemia in symptomatic carotid occlusion: prognostic value of hemodynamic factors. Neurology (2000) 1.80
Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort. Hum Reprod (2011) 1.80
The natural history of chronic hepatitis C in haemophiliacs. Br J Haematol (1996) 1.76
Decreased mortality of ischaemic heart disease among carriers of haemophilia. Lancet (2003) 1.76
Old and new risk factors for upper extremity deep venous thrombosis. J Thromb Haemost (2005) 1.73
Changes in functional outcome and quality of life in patients and caregivers after aneurysmal subarachnoid hemorrhage. J Neurosurg (2001) 1.73
Single-leg strut fractures in explanted Björk-Shiley valves. Lancet (1994) 1.71
Relationship between the diagnosis of epithelial abnormalities and the composition of cervical smears. Acta Cytol (1985) 1.70
Course of the international Normalized Ratio in response to oral vitamin K1 in patients overanticoagulated with phenprocoumon. Br J Haematol (1999) 1.69